Latest News about Briefs
Recent news which mentions Briefs
Tesla, Li Auto And MicroStrategy Are Among Top 10 Large Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?
October 26, 2024
From Benzinga
L3Harris Poised For 2025 Growth: Analysts Highlight Q3 Earnings Beat, Solid Orders, And Margin Expansion Potential
October 25, 2024
From Benzinga
Hologic Recalls Soft Tissue Marker Device BioZorb, FDA Issues Warning After Almost 400 Complaints
October 25, 2024
From Benzinga
Exxon Mobil's Golden Pass LNG Plant Gets 3-Year Extension Amid Contractor Challenges: Report
October 25, 2024
From Benzinga
What's Going On With Trump Media & Technology Group Stock On Friday?
October 25, 2024
From Benzinga
From Benzinga
Boston Beer's Strategic Moves With Hard Mtn Dew And Twisted Tea Position It For 2025 Gains, Analysts Say
October 25, 2024
From Benzinga
Eli Lilly's Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron's Dupixent
October 25, 2024
From Benzinga
Beyond Faces Uphill Battle With Declining Orders And Cash Concerns In Tough Turnaround, Analyst Downgrades Stock
October 25, 2024
From Benzinga
NextEra Energy Poised For Strong EPS Growth With Renewable Expansion, Says Goldman Sachs Analyst
October 25, 2024
From Benzinga
Analysts See Hasbro's Mixed Q3 As Pathway To Growth: Cost Cuts, Gaming, And Product Innovation In Focus
October 25, 2024
From Benzinga
Johnson & Johnson's Blockbuster Drug Tremfya Clears Plaque Psoriasis With Lesions Covering Body's Smaller Areas
October 25, 2024
From Benzinga
BKV's Integrated Operations Offer Value, Analyst Highlights Unique 'Closed-Loop' System And Growth Prospects
October 25, 2024
From Benzinga
Apple's Q3 Smartphone Sales Slip Despite Strong iPhone 16 Demand, Market Share Dropped Slightly
October 25, 2024
From Benzinga
Newell Brands Q3 Earnings: Margins Hit Highest Levels Since 2020, Boosts 2024 EPS Outlook & More
October 25, 2024
From Benzinga
Why Capri Holdings Stock Is Falling Today
October 25, 2024
From Benzinga
From Benzinga
UK Launches Antitrust Review Of Synopsys' $34 Billion Ansys Deal Over Growing Concerns
October 25, 2024
From Benzinga
Why Is Cancer-Focused Tyra Biosciences Stock Falling On Friday?
October 25, 2024
From Benzinga
Sleep Apnea Device Maker ResMed Is A Durable MedTech, With Positive Fundamentals, Says Analyst
October 25, 2024
From Benzinga
What's Going On With Nvidia, AMD And Other Chip Stocks On Friday?
October 25, 2024
From Benzinga
From Benzinga
What's Going On US-Listed Chinese Stocks On Friday?
October 25, 2024
From Benzinga
From Benzinga
From Benzinga
Trouble For US Airlines: China Demand Slump, Boeing Strike, Global Carriers Shifting Focus
October 25, 2024
From Benzinga
What's Going On With Spirit Airlines Stock Friday?
October 25, 2024
From Benzinga
Barnes Group Q3 Earnings: Aerospace Sales Jump 49%, Suspends Guidance Due To Buyout By Apollo
October 25, 2024
From Benzinga
HCA Healthcare Q3 Earnings: Revenue And Profit miss, Sees Hurricane Impact on Q4 and FY25 Earnings Growth
October 25, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.